Detalhe da pesquisa
1.
Safety and Efficacy of 48 Weeks REP 2139 or REP 2165, Tenofovir Disoproxil, and Pegylated Interferon Alfa-2a in Patients With Chronic HBV Infection Naïve to Nucleos(t)ide Therapy.
Gastroenterology
; 158(8): 2180-2194, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32147484
2.
Benefit of transaminase elevations in establishing functional cure of HBV infection during nap-based combination therapy.
J Viral Hepat
; 28(5): 817-825, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33556206